15 Most Profitable Biotechnology Companies in the World

2. Moderna 

Profit Margin: 69.32% 

Moderna’s COVID-19 vaccine, mRNA-1273, was one of the first to be authorized for emergency use in the U.S. and other countries. In 2021, Moderna shipped approximately 807 million doses of its COVID-19 vaccine globally, with approximately 25% of those doses going to low- and middle-income countries. In 2022, Moderna announced a collaboration with Carisma Therapeutics for in vivo chimeric antigen receptor monocyte (CAR-M) therapeutics for the treatment of cancer, including solid tumors.